GSEA results suggested that SF3B6 was enriched in pathways associated with the cell cycle, DNA replication, apoptosis, tumor immunity, and tumor metabolism in HCC, indicating that SF3B6 may contribute to tumor cell proliferation, tumor microenvironment formation, and tumor metabolic reprogramming. This evidence concerns the gene SF3B6 and hepatocellular carcinoma.